Experts worried about exceptions process handling under DSCSA
Regulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesBiotechnologyComplianceNorth AmericaPharmaceuticalsProduct LifecycleQuality Assurance and ControlRegulatory Intelligence/Policy